Alpha Cognition (ACOG) Metrics: History & Chart

Alpha Cognition Inc(ACOG)

Biotechnology · Grapevine, TX

$8.93-0.22 (-2.40%)

Delayed quote: Oct 6, 2026, 10:43 AM EDT

About Alpha Cognition Inc

Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company's commercial development program includes ZUNVEYL oral tablet formulation for treating Alzheimer's disease. Its pre-clinical development programs comprise ZUNVEYL in combination with memantine for the treatment of moderate-to-severe Alzheimer's disease; ALPHA-1062 sublingual formulation for acute pancreatitis; ALPHA-1062 intranasal formulation for the treatment of cognitive impairment with mild traumatic brain injury; and ALPHA-0602, ALPHA-0702, and ALPHA-0802 programs for the treatment of neurodegenerative diseases, including amyotrophic lateral sclerosis disease and spinal muscular atrophy. The company was founded in 2000 and is headquartered in Vancouver, Canada.

Grapevine, TX

71 employees

www.alphacognition.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Michael E. McFadden

View full financials

Third-Party DCF Estimate (FMP)	$6.43
Price Gap vs Third-Party Estimate	-29.76%

7D Total Return	+6.40%
30D Total Return	-3.89%
YTD Total Return	+40.77%
1Y Total Return	+22.33%
3Y Total Return	N/A
5Y Total Return	N/A
10Y Total Return	N/A
15Y Total Return	N/A
20Y Total Return	N/A

2026	+40.77%
2025	+10.36%
2024	N/A
2023	N/A
2022	N/A
2021	N/A

CAGR TTM	+22.21%
CAGR 3Y	N/A
CAGR 5Y	N/A
CAGR 10Y	N/A
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	N/A
PE Ratio Avg TTM	N/A
PE Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

All Metrics

ACOG Valuation Metrics

ACOG Stock Price Metrics

ACOG Dividend Metrics

ACOG Growth Rate Metrics

ACOG Discounted Cash Flow Metrics

ACOG Returns By Period

ACOG Yearly Returns

ACOG Average Annual Returns By Period (CAGR)

ACOG Revenue Metrics

ACOG PE Ratio Metrics

ACOG PS Ratio Metrics

ACOG PB Ratio Metrics

ACOG Price to Free Cash Flow Ratio Metrics

ACOG Debt to Equity Ratio Metrics

ACOG PEG Ratio Metrics

ACOG FCF Yield

ACOG Earnings Yield

ACOG EBITDA Yield

ACOG OCF Yield

ACOG EV/EBIT Ratio Metrics

ACOG EV/EBITDA Ratio Metrics

ACOG EV/Assets Ratio Metrics

ACOG EV/Sales Ratio Metrics

ACOG Current Ratio Metrics

ACOG Quick Ratio Metrics

ACOG ROIC Metrics

ACOG Return on Assets Metrics

ACOG Return on Equity Metrics

ACOG Net Profit Margin Metrics

ACOG Gross Profit Margin Metrics

ACOG Tax Rate Metrics

PS Ratio	13.06
PS Ratio Avg TTM	13.48
PS Ratio Avg 3Y	18.77
Current VS TTM Avg	-3.10%
Current VS 3Y Avg	-30.44%
Current VS 5Y Avg	-30.44%

PB Ratio	3.76
PB Ratio Avg TTM	2.92
PB Ratio Avg 3Y	3.05
Current VS TTM Avg	+28.87%
Current VS 3Y Avg	+23.30%
Current VS 5Y Avg	+23.30%

PFCF Ratio	N/A
PFCF Ratio Avg TTM	N/A
PFCF Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Debt/Equity Ratio	0.00
Debt/Equity Ratio Avg TTM	0.00
Debt/Equity Ratio Avg 3Y	(0.05)
Current VS TTM Avg	N/A
Current VS 3Y Avg	+100.00%
Current VS 5Y Avg	+100.00%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	N/A
FCF Yield Avg TTM	N/A
FCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Earnings Yield	N/A
Earnings Yield Avg TTM	N/A
Earnings Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	N/A
Ev/Ebit Ratio Avg TTM	N/A
Ev/Ebit Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebitda Ratio	N/A
Ev/Ebitda Ratio Avg TTM	N/A
Ev/Ebitda Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Assets Ratio	2.45
Ev/Assets Ratio Avg TTM	1.48
Ev/Assets Ratio Avg 3Y	1.58
Current VS TTM Avg	+65.15%
Current VS 3Y Avg	+54.89%
Current VS 5Y Avg	+54.89%

Ev/Sales Ratio	10.34
Ev/Sales Ratio Avg TTM	9.20
Ev/Sales Ratio Avg 3Y	12.87
Current VS TTM Avg	+12.44%
Current VS 3Y Avg	-19.68%
Current VS 5Y Avg	-19.68%

Current Ratio	9.03
Current Ratio Avg TTM	10.34
Current Ratio Avg 3Y	6.93
Current VS TTM Avg	-12.65%
Current VS 3Y Avg	+30.37%
Current VS 5Y Avg	+56.51%

Quick Ratio	8.04
Quick Ratio Avg TTM	9.62
Quick Ratio Avg 3Y	6.61
Current VS TTM Avg	-16.44%
Current VS 3Y Avg	+21.53%
Current VS 5Y Avg	+44.13%

ROIC	(50.04%)
ROIC Avg 3Y	(288.76%)
ROIC Avg 5Y	(222.94%)
Current VS 3Y Avg	+82.67%
Current VS 5Y Avg	+77.55%
Current VS 10Y Avg	+77.55%

ROA	(36.33%)
ROA Avg TTM	(11.53%)
ROA Avg 3Y	(71.63%)
Current VS TTM Avg	-214.98%
Current VS 3Y Avg	+49.28%
Current VS 5Y Avg	+42.15%

ROE	(44.26%)
ROE Avg TTM	(48.25%)
ROE Avg 3Y	(43.58%)
Current VS TTM Avg	+8.27%
Current VS 3Y Avg	-1.56%
Current VS 5Y Avg	+55.34%

Net Profit Margin	(153.61%)
Net Profit Margin Avg TTM	(250.44%)
Net Profit Margin Avg 3Y	(57.33%)
Current VS TTM Avg	+38.66%
Current VS 3Y Avg	-167.94%
Current VS 5Y Avg	-2172.51%

Gross Profit Margin	81.26%
Gross Pft Margin Avg TTM	84.51%
Gross Pft Margin Avg 3Y	38.00%
Current VS TTM Avg	-3.84%
Current VS 3Y Avg	+113.86%
Current VS 5Y Avg	+245.46%

Tax Rate	0.00%
Tax Rate Avg 3Y	N/A
Tax Rate Avg 5Y	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A
Current VS 10Y Avg	N/A